Got a stuffy nose and a cough? If you go to an urgent care or ER, chances are that you may be able find out exactly what type of germ is making you sick, thanks to newer tests that don’t look for just ...
Please provide your email address to receive an email when new articles are posted on . “Contrary to the initial intentions of the multiplex assay, our study demonstrates that the inherent advantages ...
Marlborough, Massachusetts-based Hologic already offers molecular diagnostic tests. But diagnostics companies have been looking to add multiplex offerings—the capability to identify multiple pathogens ...
Molecular Designs, a developer and manufacturer of molecular infectious disease assays, today announced it has submitted a ...
The "Molecular Diagnostics for Infectious Disease – Market Forecasts, Strategies and Trends – By Syndrome and by Country – With Multiplex and Point of Care Market Analysis, Executive Guides and ...
AliveDx registers MosaiQ®, its Instrument for Multiplex Testing of Autoimmune Diseases, Allergies and Beyond, as a Class II Exempt Device with the U.S. Food and Drug Administration (FDA) Provided by ...
SYDNEY--(BUSINESS WIRE)--SpeeDx Pty. Ltd. today announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA). The company anticipates clearance in time for the ...
Claims for unregulated rapid molecular diagnostic tests for urinary tract infections (UTIs) in older adults have soared 60-fold from 2016 to 2023, according to Medicare data. The rise was most ...
QIAGEN’s NeuMoDx test has received emergency use authorization from the U.S. Food and Drug Administration (FDA). The test helps to quickly identify and differentiate individuals suspected of ...
QIAGEN N.V. QGEN recently received Emergency Use Authorization (EUA) from the FDA for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay. Notably, the polymerase chain reaction (PCR) multiplex test will ...
The MosaiQ solution is a next-generation IVD solution for autoimmune diseases, allergies and beyond. The multiplexed, fully automated planar microarray platform enables syndromic testing for complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results